Lantheus vs QuidelOrtho
LNTH and QDEL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LNTH and QDEL compare
Lantheus is the larger company, worth 9.5 times as much as QuidelOrtho ($6.6B against $700M).
Lantheus grew revenue faster over the last twelve months (2.3% versus −4.5% for QuidelOrtho).
Lantheus keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with −14.2% at QuidelOrtho.
Lantheus scores higher on the StockData Score (11 against 6 for QuidelOrtho), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LNTH | QDEL |
|---|---|---|
| Size and price | ||
| Market cap | $6.6B | $700M |
| Share price | $101.72 | $10.21 |
| Change, 1 year | 91.5% | −54.0% |
| Change, 5 years | 265% | −92.9% |
| Beta (5Y) | 0.41 | 1.27 |
| Employees | 1,193 | 6,500 |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 5 (better) | 2 |
| Health score | 4 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 24.6× | – |
| P/S | 4.3× | 0.3× (better) |
| P/B | 5.1× | 0.4× (better) |
| EV/EBITDA | 16.9× | 10.4× (better) |
| PEG | 0.24 | – |
| FCF yield | – | −16.7% |
| Fair value | $91.21 | $26.84 |
| Margin of safety | −11.5% | 62.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 2.3% (better) | −4.5% |
| Revenue growth, 5Y average | 35.3% (better) | 10.4% |
| Net income growth (TTM) | 1.6% | – |
| EPS growth (TTM) | 9.5% | – |
| Profitability | ||
| Gross margin | 60.1% (better) | 44.2% |
| Operating margin | 19.4% (better) | −4.9% |
| Net margin | 17.7% (better) | −14.2% |
| FCF margin | – | −4.5% |
| Return on equity | 22.2% (better) | −19.3% |
| Return on invested capital | 19.7% (better) | −2.2% |
| Financial health | ||
| Debt / equity | 0.44 (better) | 1.64 |
| Net debt / EBITDA | −0.06 | 8.29 (better) |
| Interest coverage | 15.3× (better) | −0.6× |
| Current ratio | 3.06 (better) | 1.36 |
| Altman Z-score | 5.52 (better) | 0.26 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −0.64% |
| Shareholder yield | 0.00% (better) | −0.64% |
| Ownership | ||
| Held by institutions | 117% | 121% |
| Held by insiders | 2.3% | 43.4% |
| Insider net buying, 12 months | – | $669K |
| Short interest, % of float | 5.7% | 37.3% |
Go deeper
- LNTH stock overview
- LNTH income statement
- LNTH valuation and score
- QDEL stock overview
- QDEL income statement
- QDEL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.